Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: A4HAQ6
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0036094 | small molecule binding | 2 | 8 |
GO:0051287 | NAD binding | 4 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901265 | nucleoside phosphate binding | 3 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.220 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.218 |
CLV_PCSK_KEX2_1 | 174 | 176 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.220 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.218 |
CLV_PCSK_PC1ET2_1 | 174 | 176 | PF00082 | 0.453 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.225 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.217 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.495 |
DOC_MAPK_gen_1 | 110 | 118 | PF00069 | 0.495 |
DOC_MAPK_gen_1 | 17 | 27 | PF00069 | 0.389 |
DOC_MAPK_gen_1 | 28 | 35 | PF00069 | 0.420 |
DOC_MAPK_gen_1 | 65 | 73 | PF00069 | 0.569 |
DOC_MAPK_HePTP_8 | 155 | 167 | PF00069 | 0.389 |
DOC_MAPK_MEF2A_6 | 112 | 120 | PF00069 | 0.410 |
DOC_MAPK_MEF2A_6 | 158 | 167 | PF00069 | 0.389 |
DOC_SPAK_OSR1_1 | 68 | 72 | PF12202 | 0.389 |
DOC_USP7_UBL2_3 | 14 | 18 | PF12436 | 0.252 |
LIG_14-3-3_CanoR_1 | 122 | 131 | PF00244 | 0.454 |
LIG_14-3-3_CanoR_1 | 181 | 189 | PF00244 | 0.464 |
LIG_BRCT_BRCA1_1 | 113 | 117 | PF00533 | 0.452 |
LIG_deltaCOP1_diTrp_1 | 16 | 22 | PF00928 | 0.438 |
LIG_LIR_Gen_1 | 106 | 116 | PF02991 | 0.433 |
LIG_LIR_Gen_1 | 16 | 27 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 114 | 120 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 16 | 22 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 186 | 191 | PF02991 | 0.652 |
LIG_LIR_Nem_3 | 5 | 11 | PF02991 | 0.466 |
LIG_Pex14_2 | 103 | 107 | PF04695 | 0.420 |
LIG_PTB_Apo_2 | 101 | 108 | PF02174 | 0.389 |
LIG_REV1ctd_RIR_1 | 100 | 109 | PF16727 | 0.434 |
LIG_TYR_ITIM | 35 | 40 | PF00017 | 0.410 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.388 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.420 |
MOD_CK2_1 | 79 | 85 | PF00069 | 0.452 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.218 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.262 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.565 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.384 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.595 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.521 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.448 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.501 |
MOD_PIKK_1 | 122 | 128 | PF00454 | 0.506 |
MOD_PKA_2 | 180 | 186 | PF00069 | 0.468 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.462 |
MOD_Plk_1 | 79 | 85 | PF00069 | 0.452 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.454 |
MOD_SUMO_rev_2 | 61 | 66 | PF00179 | 0.452 |
TRG_ENDOCYTIC_2 | 37 | 40 | PF00928 | 0.450 |
TRG_ER_diArg_1 | 157 | 160 | PF00400 | 0.389 |
TRG_ER_diArg_1 | 27 | 29 | PF00400 | 0.420 |
TRG_ER_diArg_1 | 58 | 60 | PF00400 | 0.418 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JA38 | Bodo saltans | 41% | 69% |
A0A3R7MNZ9 | Trypanosoma rangeli | 51% | 92% |
A0A422MS45 | Trypanosoma rangeli | 56% | 92% |
A0A422MS54 | Trypanosoma rangeli | 59% | 71% |
A4I9V3 | Leishmania infantum | 68% | 94% |
E9B4W5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 71% | 100% |